The company have demonstrably advanced the course of a new treatment for cardiac amyloidosis, employing Attruby. Early patient information suggests significant improvements for patients suffering by this debilitating illness. This focus underscores BridgeBio's commitment to treating critical patient needs in a heart space. Attruby: Brid… Read More